Stay updated on ABO-102 Gene Transfer in MPS IIIA Clinical Trial
Sign up to get notified when there's something new on the ABO-102 Gene Transfer in MPS IIIA Clinical Trial page.

Latest updates to the ABO-102 Gene Transfer in MPS IIIA Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedLocations section updated to include Pennsylvania and South Australia; the HHS Vulnerability Disclosure link was removed.SummaryDifference0.3%

- Check19 days agoNo Change Detected
- Check27 days agoNo Change Detected
- Check41 days agoChange DetectedThe page now shows Revision: v3.3.2 and the earlier Revision: v3.2.0 has been removed.SummaryDifference0.1%

- Check48 days agoChange DetectedThe government funding lapse notice about NIH operations was removed from the page. The study details, eligibility criteria, and contact information remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check63 days agoChange DetectedThe study record is marked as Terminated due to lack of efficacy in advanced MPS IIIA patients. Termination dates and related status updates are reflected.SummaryDifference0.4%

- Check91 days agoChange DetectedUpdated to v3.2.0 and added a government funding operating-status notice; deprecation of the v3.1.0 item.SummaryDifference3%

- Check98 days agoChange Detected- Updated disease naming from broader terms to a precise one (Mucopolysaccharidosis type 3A) to reflect specificity. - Updated revision/version to v3.1.0 from v3.0.2.SummaryDifference0.3%

Stay in the know with updates to ABO-102 Gene Transfer in MPS IIIA Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ABO-102 Gene Transfer in MPS IIIA Clinical Trial page.